Kjersti M Staby1, Karsten Gravdal1, Sverre J Mørk1,2, Steffen Heegaard3,4, Olav K Vintermyr1,2, Jørgen Krohn5,6. 1. Department of Pathology, Haukeland University Hospital, Bergen, Norway. 2. The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. 3. Department of Ophthalmology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. 4. Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. 5. Department of Clinical Medicine, Section of Ophthalmology, University of Bergen, Bergen, Norway. 6. Department of Ophthalmology, Haukeland University Hospital, Bergen, Norway.
Abstract
PURPOSE: To evaluate clinico-pathological and molecular prognostic factors in a well-defined series of posterior uveal melanoma (UM) with focus on chromosomal aberrations and mutations in the GNAQ, GNA11 and BRCA1-associated protein 1 (BAP1) genes. METHODS: Formalin-fixed paraffin-embedded (FFPE) tissue samples were obtained from 50 consecutive eyes enucleated for UM between 1993 and 2005. The material was tested for loss of chromosome 3 and gain of chromosome 8q gene signatures by selective molecular gene markers using multiplex ligation-dependent probe amplification (MLPA), and for DNA mutations in the GNAQ, GNA11 and BAP1 genes. RESULTS: After a mean follow-up of 83 months (range, 8-205 months), 21 patients had died of metastatic UM and 16 patients of other causes. Tumour diameter, ciliary body involvement, mixed/epithelioid cell types, mitotic index, Ki-67 proliferation index, loss of chromosome 3 and gain of chromosome 8q showed statistically significant associations with metastatic disease. There were no significant differences in the prevalence of GNAQ and GNA11 mutations between patients with or without metastatic disease. Mutational analysis of the BAP1 gene was performed in 32 primary UM and in five UM liver metastases. Nine different BAP1 missense mutations were identified. BAP1 mutations were not more common in metastasizing than in nonmetastasizing UM. CONCLUSION: The molecular gene markers showing loss of chromosome 3 and gain of 8q gene signatures were associated with an increased risk of metastatic disease. BRCA1-associated protein 1 (BAP1) gene mutation status had no prognostic significance. The frequency and spectrum of BAP1 mutations in UM may be more dependent on ethnicity and demographic variables than hitherto considered.
PURPOSE: To evaluate clinico-pathological and molecular prognostic factors in a well-defined series of posterior uveal melanoma (UM) with focus on chromosomal aberrations and mutations in the GNAQ, GNA11 and BRCA1-associated protein 1 (BAP1) genes. METHODS:Formalin-fixed paraffin-embedded (FFPE) tissue samples were obtained from 50 consecutive eyes enucleated for UM between 1993 and 2005. The material was tested for loss of chromosome 3 and gain of chromosome 8q gene signatures by selective molecular gene markers using multiplex ligation-dependent probe amplification (MLPA), and for DNA mutations in the GNAQ, GNA11 and BAP1 genes. RESULTS: After a mean follow-up of 83 months (range, 8-205 months), 21 patients had died of metastatic UM and 16 patients of other causes. Tumour diameter, ciliary body involvement, mixed/epithelioid cell types, mitotic index, Ki-67 proliferation index, loss of chromosome 3 and gain of chromosome 8q showed statistically significant associations with metastatic disease. There were no significant differences in the prevalence of GNAQ and GNA11 mutations between patients with or without metastatic disease. Mutational analysis of the BAP1 gene was performed in 32 primary UM and in five UM liver metastases. Nine different BAP1 missense mutations were identified. BAP1 mutations were not more common in metastasizing than in nonmetastasizing UM. CONCLUSION: The molecular gene markers showing loss of chromosome 3 and gain of 8q gene signatures were associated with an increased risk of metastatic disease. BRCA1-associated protein 1 (BAP1) gene mutation status had no prognostic significance. The frequency and spectrum of BAP1 mutations in UM may be more dependent on ethnicity and demographic variables than hitherto considered.
Authors: Paula Silva-Rodríguez; Daniel Fernández-Díaz; Manuel Bande; María Pardo; Lourdes Loidi; María José Blanco-Teijeiro Journal: Cancers (Basel) Date: 2022-06-22 Impact factor: 6.575
Authors: Susan Kennedy; Michael Rice; Sinead Toomey; Noel Horgan; Bryan T Hennessey; Annemarie Larkin Journal: J Cancer Res Clin Oncol Date: 2018-07-14 Impact factor: 4.553
Authors: Kevin Yang; Allen S W Oak; Radomir M Slominski; Anna A Brożyna; Andrzej T Slominski Journal: Int J Mol Sci Date: 2020-05-16 Impact factor: 5.923
Authors: Anja Wessely; Theresa Steeb; Michael Erdmann; Lucie Heinzerling; Julio Vera; Max Schlaak; Carola Berking; Markus Vincent Heppt Journal: Int J Mol Sci Date: 2020-01-29 Impact factor: 5.923
Authors: Mitchell S Stark; Elin S Gray; Timothy Isaacs; Fred K Chen; Michael Millward; Ashleigh McEvoy; Pauline Zaenker; Melanie Ziman; H Peter Soyer; William J Glasson; Sunil K Warrier; Andrew L Stark; Olivia J Rolfe; Jane M Palmer; Nicholas K Hayward Journal: Transl Vis Sci Technol Date: 2019-11-14 Impact factor: 3.283
Authors: Natasha M van Poppelen; Daniël P de Bruyn; Tolga Bicer; Rob Verdijk; Nicole Naus; Hanneke Mensink; Dion Paridaens; Annelies de Klein; Erwin Brosens; Emine Kiliҫ Journal: Int J Mol Sci Date: 2020-12-30 Impact factor: 5.923